nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Etoposide—muscle cancer	0.118	0.526	CbGbCtD
Hydromorphone—CYP3A4—Vincristine—muscle cancer	0.0302	0.134	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—muscle cancer	0.0297	0.132	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—muscle cancer	0.0277	0.123	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—muscle cancer	0.0189	0.084	CbGbCtD
Hydromorphone—Insomnia—Vincristine—muscle cancer	0.0015	0.00194	CcSEcCtD
Hydromorphone—Paraesthesia—Vincristine—muscle cancer	0.00149	0.00192	CcSEcCtD
Hydromorphone—Malaise—Etoposide—muscle cancer	0.00149	0.00192	CcSEcCtD
Hydromorphone—Breast disorder—Methotrexate—muscle cancer	0.00148	0.00191	CcSEcCtD
Hydromorphone—Vertigo—Etoposide—muscle cancer	0.00148	0.00191	CcSEcCtD
Hydromorphone—Leukopenia—Etoposide—muscle cancer	0.00147	0.0019	CcSEcCtD
Hydromorphone—Abdominal pain—Dactinomycin—muscle cancer	0.00147	0.00189	CcSEcCtD
Hydromorphone—Body temperature increased—Dactinomycin—muscle cancer	0.00147	0.00189	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00147	0.00189	CcSEcCtD
Hydromorphone—Loss of consciousness—Etoposide—muscle cancer	0.00145	0.00187	CcSEcCtD
Hydromorphone—Lethargy—Doxorubicin—muscle cancer	0.00145	0.00187	CcSEcCtD
Hydromorphone—Decreased appetite—Vincristine—muscle cancer	0.00144	0.00186	CcSEcCtD
Hydromorphone—Cough—Etoposide—muscle cancer	0.00144	0.00185	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00143	0.00185	CcSEcCtD
Hydromorphone—Fatigue—Vincristine—muscle cancer	0.00143	0.00185	CcSEcCtD
Hydromorphone—Convulsion—Etoposide—muscle cancer	0.00143	0.00184	CcSEcCtD
Hydromorphone—Hyponatraemia—Doxorubicin—muscle cancer	0.00142	0.00184	CcSEcCtD
Hydromorphone—Hypertension—Etoposide—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Pain—Vincristine—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Constipation—Vincristine—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Pain in extremity—Doxorubicin—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Osteoarthritis—Doxorubicin—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Diplopia—Doxorubicin—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Asthma—Methotrexate—muscle cancer	0.00142	0.00183	CcSEcCtD
Hydromorphone—Chest pain—Etoposide—muscle cancer	0.0014	0.00181	CcSEcCtD
Hydromorphone—Migraine—Doxorubicin—muscle cancer	0.0014	0.0018	CcSEcCtD
Hydromorphone—Affect lability—Doxorubicin—muscle cancer	0.0014	0.0018	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00139	0.0018	CcSEcCtD
Hydromorphone—Discomfort—Etoposide—muscle cancer	0.00139	0.00179	CcSEcCtD
Hydromorphone—Hypersensitivity—Dactinomycin—muscle cancer	0.00137	0.00177	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Vincristine—muscle cancer	0.00136	0.00175	CcSEcCtD
Hydromorphone—Confusional state—Etoposide—muscle cancer	0.00136	0.00175	CcSEcCtD
Hydromorphone—Cardiac arrest—Doxorubicin—muscle cancer	0.00135	0.00174	CcSEcCtD
Hydromorphone—Anaphylactic shock—Etoposide—muscle cancer	0.00134	0.00173	CcSEcCtD
Hydromorphone—Mood swings—Doxorubicin—muscle cancer	0.00134	0.00173	CcSEcCtD
Hydromorphone—Infection—Etoposide—muscle cancer	0.00134	0.00172	CcSEcCtD
Hydromorphone—Asthenia—Dactinomycin—muscle cancer	0.00133	0.00172	CcSEcCtD
Hydromorphone—Dysuria—Methotrexate—muscle cancer	0.00132	0.00171	CcSEcCtD
Hydromorphone—Dehydration—Doxorubicin—muscle cancer	0.00132	0.0017	CcSEcCtD
Hydromorphone—Tachycardia—Etoposide—muscle cancer	0.00131	0.00169	CcSEcCtD
Hydromorphone—Body temperature increased—Vincristine—muscle cancer	0.00131	0.00169	CcSEcCtD
Hydromorphone—Abdominal pain—Vincristine—muscle cancer	0.00131	0.00169	CcSEcCtD
Hydromorphone—Skin disorder—Etoposide—muscle cancer	0.00131	0.00168	CcSEcCtD
Hydromorphone—Erectile dysfunction—Methotrexate—muscle cancer	0.0013	0.00168	CcSEcCtD
Hydromorphone—Hyperhidrosis—Etoposide—muscle cancer	0.0013	0.00168	CcSEcCtD
Hydromorphone—Abdominal pain upper—Doxorubicin—muscle cancer	0.0013	0.00167	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.0013	0.00167	CcSEcCtD
Hydromorphone—Breast disorder—Doxorubicin—muscle cancer	0.00128	0.00165	CcSEcCtD
Hydromorphone—Anorexia—Etoposide—muscle cancer	0.00128	0.00165	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00128	0.00165	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—muscle cancer	0.00127	0.00164	CcSEcCtD
Hydromorphone—Nasopharyngitis—Doxorubicin—muscle cancer	0.00127	0.00164	CcSEcCtD
Hydromorphone—Drowsiness—Methotrexate—muscle cancer	0.00126	0.00163	CcSEcCtD
Hydromorphone—Infestation—Methotrexate—muscle cancer	0.00126	0.00163	CcSEcCtD
Hydromorphone—Infestation NOS—Methotrexate—muscle cancer	0.00126	0.00163	CcSEcCtD
Hydromorphone—Depression—Methotrexate—muscle cancer	0.00126	0.00162	CcSEcCtD
Hydromorphone—Hypotension—Etoposide—muscle cancer	0.00126	0.00162	CcSEcCtD
Hydromorphone—Gastritis—Doxorubicin—muscle cancer	0.00126	0.00162	CcSEcCtD
Hydromorphone—Muscular weakness—Doxorubicin—muscle cancer	0.00125	0.00161	CcSEcCtD
Hydromorphone—Abdominal distension—Doxorubicin—muscle cancer	0.00123	0.00159	CcSEcCtD
Hydromorphone—Stomatitis—Methotrexate—muscle cancer	0.00123	0.00159	CcSEcCtD
Hydromorphone—Asthma—Doxorubicin—muscle cancer	0.00123	0.00158	CcSEcCtD
Hydromorphone—Dysphagia—Doxorubicin—muscle cancer	0.00123	0.00158	CcSEcCtD
Hydromorphone—Hypersensitivity—Vincristine—muscle cancer	0.00122	0.00158	CcSEcCtD
Hydromorphone—Sweating—Methotrexate—muscle cancer	0.00121	0.00156	CcSEcCtD
Hydromorphone—Paraesthesia—Etoposide—muscle cancer	0.00121	0.00156	CcSEcCtD
Hydromorphone—Dyspnoea—Etoposide—muscle cancer	0.0012	0.00155	CcSEcCtD
Hydromorphone—Somnolence—Etoposide—muscle cancer	0.0012	0.00154	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Methotrexate—muscle cancer	0.00119	0.00154	CcSEcCtD
Hydromorphone—Asthenia—Vincristine—muscle cancer	0.00119	0.00154	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—muscle cancer	0.00118	0.00152	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—muscle cancer	0.00117	0.00151	CcSEcCtD
Hydromorphone—Decreased appetite—Etoposide—muscle cancer	0.00117	0.00151	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Etoposide—muscle cancer	0.00116	0.0015	CcSEcCtD
Hydromorphone—Fatigue—Etoposide—muscle cancer	0.00116	0.00149	CcSEcCtD
Hydromorphone—Pain—Etoposide—muscle cancer	0.00115	0.00148	CcSEcCtD
Hydromorphone—Constipation—Etoposide—muscle cancer	0.00115	0.00148	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—muscle cancer	0.00115	0.00148	CcSEcCtD
Hydromorphone—Diarrhoea—Vincristine—muscle cancer	0.00114	0.00146	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—muscle cancer	0.00113	0.00146	CcSEcCtD
Hydromorphone—Urinary tract disorder—Methotrexate—muscle cancer	0.00112	0.00144	CcSEcCtD
Hydromorphone—Urethral disorder—Methotrexate—muscle cancer	0.00111	0.00143	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—muscle cancer	0.00111	0.00143	CcSEcCtD
Hydromorphone—Feeling abnormal—Etoposide—muscle cancer	0.00111	0.00143	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—muscle cancer	0.0011	0.00142	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Etoposide—muscle cancer	0.0011	0.00142	CcSEcCtD
Hydromorphone—Dizziness—Vincristine—muscle cancer	0.0011	0.00142	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—muscle cancer	0.00109	0.00141	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—muscle cancer	0.00109	0.00141	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—muscle cancer	0.00109	0.00141	CcSEcCtD
Hydromorphone—Visual impairment—Methotrexate—muscle cancer	0.00109	0.00141	CcSEcCtD
Hydromorphone—Urticaria—Etoposide—muscle cancer	0.00107	0.00138	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—muscle cancer	0.00107	0.00137	CcSEcCtD
Hydromorphone—Body temperature increased—Etoposide—muscle cancer	0.00106	0.00137	CcSEcCtD
Hydromorphone—Abdominal pain—Etoposide—muscle cancer	0.00106	0.00137	CcSEcCtD
Hydromorphone—Eye disorder—Methotrexate—muscle cancer	0.00106	0.00137	CcSEcCtD
Hydromorphone—Tinnitus—Methotrexate—muscle cancer	0.00106	0.00136	CcSEcCtD
Hydromorphone—Vomiting—Vincristine—muscle cancer	0.00106	0.00136	CcSEcCtD
Hydromorphone—Cardiac disorder—Methotrexate—muscle cancer	0.00105	0.00136	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—muscle cancer	0.00105	0.00135	CcSEcCtD
Hydromorphone—Rash—Vincristine—muscle cancer	0.00105	0.00135	CcSEcCtD
Hydromorphone—Dermatitis—Vincristine—muscle cancer	0.00105	0.00135	CcSEcCtD
Hydromorphone—Headache—Vincristine—muscle cancer	0.00104	0.00134	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00103	0.00133	CcSEcCtD
Hydromorphone—Angiopathy—Methotrexate—muscle cancer	0.00103	0.00133	CcSEcCtD
Hydromorphone—Immune system disorder—Methotrexate—muscle cancer	0.00102	0.00132	CcSEcCtD
Hydromorphone—Mediastinal disorder—Methotrexate—muscle cancer	0.00102	0.00132	CcSEcCtD
Hydromorphone—Chills—Methotrexate—muscle cancer	0.00102	0.00131	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—muscle cancer	0.000999	0.00129	CcSEcCtD
Hydromorphone—Mental disorder—Methotrexate—muscle cancer	0.000993	0.00128	CcSEcCtD
Hydromorphone—Hypersensitivity—Etoposide—muscle cancer	0.000991	0.00128	CcSEcCtD
Hydromorphone—Malnutrition—Methotrexate—muscle cancer	0.000987	0.00127	CcSEcCtD
Hydromorphone—Erythema—Methotrexate—muscle cancer	0.000987	0.00127	CcSEcCtD
Hydromorphone—Nausea—Vincristine—muscle cancer	0.000986	0.00127	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—muscle cancer	0.000984	0.00127	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000977	0.00126	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000969	0.00125	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—muscle cancer	0.000967	0.00125	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—muscle cancer	0.000966	0.00125	CcSEcCtD
Hydromorphone—Asthenia—Etoposide—muscle cancer	0.000965	0.00124	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000965	0.00124	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—muscle cancer	0.000962	0.00124	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—muscle cancer	0.000955	0.00123	CcSEcCtD
Hydromorphone—Pruritus—Etoposide—muscle cancer	0.000951	0.00123	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—muscle cancer	0.000946	0.00122	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—muscle cancer	0.00093	0.0012	CcSEcCtD
Hydromorphone—Diarrhoea—Etoposide—muscle cancer	0.00092	0.00119	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—muscle cancer	0.000917	0.00118	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—muscle cancer	0.000916	0.00118	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—muscle cancer	0.000915	0.00118	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—muscle cancer	0.000911	0.00117	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—muscle cancer	0.000911	0.00117	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—muscle cancer	0.000891	0.00115	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—muscle cancer	0.00089	0.00115	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—muscle cancer	0.000889	0.00115	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—muscle cancer	0.000887	0.00114	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—muscle cancer	0.000887	0.00114	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000885	0.00114	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—muscle cancer	0.000883	0.00114	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—muscle cancer	0.000881	0.00114	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—muscle cancer	0.000877	0.00113	CcSEcCtD
Hydromorphone—Cough—Methotrexate—muscle cancer	0.000861	0.00111	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—muscle cancer	0.00086	0.00111	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—muscle cancer	0.000855	0.0011	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—muscle cancer	0.000855	0.0011	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—muscle cancer	0.000855	0.0011	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—muscle cancer	0.000855	0.0011	CcSEcCtD
Hydromorphone—Rash—Etoposide—muscle cancer	0.000848	0.00109	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—muscle cancer	0.000847	0.00109	CcSEcCtD
Hydromorphone—Headache—Etoposide—muscle cancer	0.000842	0.00109	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—muscle cancer	0.000842	0.00109	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—muscle cancer	0.00084	0.00108	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—muscle cancer	0.00084	0.00108	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—muscle cancer	0.00084	0.00108	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—muscle cancer	0.000839	0.00108	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—muscle cancer	0.000837	0.00108	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000834	0.00108	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—muscle cancer	0.00083	0.00107	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—muscle cancer	0.00083	0.00107	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—muscle cancer	0.000827	0.00107	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—muscle cancer	0.000822	0.00106	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—muscle cancer	0.000812	0.00105	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—muscle cancer	0.000805	0.00104	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—muscle cancer	0.000805	0.00104	CcSEcCtD
Hydromorphone—Infection—Methotrexate—muscle cancer	0.0008	0.00103	CcSEcCtD
Hydromorphone—Nausea—Etoposide—muscle cancer	0.000799	0.00103	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000793	0.00102	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—muscle cancer	0.00079	0.00102	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—muscle cancer	0.000785	0.00101	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—muscle cancer	0.000782	0.00101	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—muscle cancer	0.000779	0.001	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—muscle cancer	0.000771	0.000994	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—muscle cancer	0.000768	0.00099	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—muscle cancer	0.000768	0.00099	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—muscle cancer	0.000766	0.000988	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—muscle cancer	0.000765	0.000986	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—muscle cancer	0.000755	0.000974	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—muscle cancer	0.000753	0.000971	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—muscle cancer	0.000751	0.000969	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—muscle cancer	0.000746	0.000962	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—muscle cancer	0.00074	0.000955	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—muscle cancer	0.000738	0.000951	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000734	0.000946	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—muscle cancer	0.000728	0.000939	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—muscle cancer	0.000727	0.000938	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—muscle cancer	0.000727	0.000938	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—muscle cancer	0.000727	0.000938	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—muscle cancer	0.000725	0.000935	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—muscle cancer	0.000723	0.000933	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000722	0.000932	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—muscle cancer	0.000719	0.000927	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—muscle cancer	0.000718	0.000926	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—muscle cancer	0.000716	0.000923	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—muscle cancer	0.000711	0.000918	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—muscle cancer	0.000709	0.000914	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—muscle cancer	0.000703	0.000907	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—muscle cancer	0.0007	0.000903	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000697	0.000899	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000695	0.000897	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—muscle cancer	0.000694	0.000895	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—muscle cancer	0.000693	0.000893	CcSEcCtD
Hydromorphone—Pain—Methotrexate—muscle cancer	0.000689	0.000888	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—muscle cancer	0.000686	0.000885	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—muscle cancer	0.000684	0.000882	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—muscle cancer	0.000681	0.000878	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—muscle cancer	0.000677	0.000874	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000674	0.000869	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—muscle cancer	0.000665	0.000857	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—muscle cancer	0.000664	0.000856	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000659	0.000849	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—muscle cancer	0.000652	0.00084	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—muscle cancer	0.00064	0.000825	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—muscle cancer	0.000637	0.000821	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—muscle cancer	0.000637	0.000821	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000635	0.000819	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—muscle cancer	0.000631	0.000813	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—muscle cancer	0.000626	0.000808	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—muscle cancer	0.000622	0.000802	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—muscle cancer	0.00062	0.0008	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—muscle cancer	0.000614	0.000792	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—muscle cancer	0.000606	0.000782	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000602	0.000776	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—muscle cancer	0.000601	0.000775	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—muscle cancer	0.000596	0.000769	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—muscle cancer	0.000596	0.000769	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—muscle cancer	0.000593	0.000765	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—muscle cancer	0.000578	0.000745	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—muscle cancer	0.000575	0.000741	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00057	0.000735	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—muscle cancer	0.00057	0.000735	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—muscle cancer	0.000554	0.000714	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—muscle cancer	0.000551	0.000711	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—muscle cancer	0.000551	0.000711	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—muscle cancer	0.000551	0.000711	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—muscle cancer	0.000533	0.000687	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—muscle cancer	0.000514	0.000663	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—muscle cancer	0.000512	0.00066	CcSEcCtD
Hydromorphone—Rash—Methotrexate—muscle cancer	0.000508	0.000655	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—muscle cancer	0.000507	0.000654	CcSEcCtD
Hydromorphone—Headache—Methotrexate—muscle cancer	0.000505	0.000651	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—muscle cancer	0.0005	0.000645	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—muscle cancer	0.000493	0.000636	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—muscle cancer	0.000478	0.000617	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—muscle cancer	0.000477	0.000615	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—muscle cancer	0.000461	0.000595	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—muscle cancer	0.000443	0.000572	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—muscle cancer	0.00044	0.000567	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—muscle cancer	0.000439	0.000567	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—muscle cancer	0.000437	0.000563	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—muscle cancer	0.000414	0.000534	CcSEcCtD
